Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Interleukin 1alpha rs1800587 associates with chronic non-crisis pain in sickle cell disease
source: The Journal of Pain
year: 2016
authors: X. Hu, E. Jhun, Y. Yao, Y. He, R. Molokie, D. Wilkie, Z. Wang
summary/abstract:Pain is prevalent in sickle cell disease (SCD) patients who display great heterogeneity in pain severity and frequency. Studying the contribution of relevant candidate gene polymorphisms may shed light on the etiology of the pain heterogeneity, allowing for precision pain medicine in SCD. We hypothesize that inflammatory factors are involved in the pathogenesis of sickle cell pain. In this study, we focused on the IL1A C/T polymorphism rs1800587 that is a single nucleotide polymorphism (SNP) located at position -889. The SNP came to our attention because our bioinformatic analysis predicted that this SNP is located in a cis-transcriptional regulatory region modulating the protein expression level. Pain phenotype data were gathered from PAINReportIt, a pain assessment tool for multidimensional pain experience. The composite pain index (CPI) was used as a measurement for the baseline pain. Utilization of urgent or emergency care due to sickling pain crisis was used as a surrogate for acute pain crisis in SCD. We found the T allele was associated with increased CPI. In our SCD cohort, each T allele was associated with a 3.9 increase in CPI (p=0.04), accounting for 3% of variability in CPI as determined by the additive multiple linear regression. We did not find significant association between this SNP and the patient utilization due to acute pain. These results represent the first indication that IL1A rs1800587 may influence the chronic non-crisis pain in SCD.
organization: Department of Biopharmaceutical Sciences and Sickle Cell Center, University of Illinois, ChicagoDOI: 10.1016/j.jpain.2016.01.186
read more
+myBinderRelated Content
-
World Sickle Cell Awareness DaySince 2008, World Sickle Cell Awareness ...
-
Z. Jim Wang, PhDDr. Wang is a professor of pharmacology ...
-
Your Healthcare TeamTo seek clinical care for your sickle ce...
-
Jennifer Krajewski, MDJennifer Krajewski has served the Pediat...
-
Newborn Screening Guide for ParentsMost babies born in the United States ar...
-
Crux of the matter with Elsie: Sexual Disposition of Sickle Cell WarriorsWhether we like it or not, sex is import...
-
Capitol Hill Briefing Held to Encourage Sickle Cell Research and TreatmentEarlier today, a briefing was hosted on ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.